The BU Annual Fund Leadership Giving Society presents a conversation with Dr.
Federal Court Supports NIH Review of Biolab Safety Risks; BU’s NEIDL Moves Closer to Full Operation
Original article from: BU Today, posted on October 1, 2013. By Art Jahnke
In an action that moves BU’s National Emerging Infectious Diseases Laboratories(NEIDL) closer to full operation, a federal court judge has ruled that a Final Supplementary Risk Assessment prepared by the National Institutes of Health(NIH) adequately analyzes the risks associated with research involving pathogens at BioSafety Level 3 (BSL-3) and BioSafety Level 4 (BSL-4) and that such research can be done safely at the BU Medical Campus site.
That risk assessment, which examined a series of scenarios and potential consequences of procedural failures, including containment system failures and malevolent acts, had been challenged in court by a number of Boston residents and the Conservation Law Foundation. The groups claimed that the risk assessment prepared by the NIH was not adequate and that the NIH decision to approve it was arbitrary and capricious.